Literature DB >> 22498718

Effect of RhoA on transforming growth factor β1-induced rat hepatic stellate cell migration.

Lei Li1, Ji-Yao Wang, Chang-Qing Yang, Wei Jiang.   

Abstract

BACKGROUND: Although the migration of hepatic stellate cells (HSCs) is essential to the hepatic fibrotic response, the intracellular and extracellular signals that regulate their migration are poorly understood. AIMS: To investigate the role of Rho guanosine triphosphatase (Rho GTPase) signalling, specifically via RhoA, in transforming growth factor β1 (TGFβ1)-induced HSC migration.
METHODS: Both primary rat HSCs and the HSC-T6 rat hepatic stellate cell line were used in this study. Cell migration was evaluated using the Transwell Boyden Chamber assay, whereas cytoskeletal changes were observed using laser confocal microscopy. Western blotting was used to detect the expression of Rho GTPases (RhoA, Rac1 and Cdc42) in HSCs, and their activation was determined using glutathione S-transferase (GST) pull-down assays. Finally, the specific effects of RhoA on TGFβ1-induced cell migration were analysed in HSC-T6 cells stably transfected with constitutively active (CA, Q63L) or dominant-negative (DN, T19N) RhoA mutants.
RESULTS: Transforming growth factor β1 induced cytoskeletal remodelling and migration of rat HSCs following RhoA activation. The level of RhoA activation determined the motility of the HSCs.
CONCLUSIONS: These findings broaden our understanding of the intracellular and extracellular signals that regulate HSC migration. Furthermore, RhoA may be a candidate therapeutic target for hepatic fibrosis.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22498718     DOI: 10.1111/j.1478-3231.2012.02809.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  14 in total

Review 1.  siRNA- and miRNA-based therapeutics for liver fibrosis.

Authors:  Zhen Zhao; Chien-Yu Lin; Kun Cheng
Journal:  Transl Res       Date:  2019-08-13       Impact factor: 7.012

Review 2.  Mechanisms of liver fibrosis and its role in liver cancer.

Authors:  Debanjan Dhar; Jacopo Baglieri; Tatiana Kisseleva; David A Brenner
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-10

3.  High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice.

Authors:  Xiaodong Ge; Elena Arriazu; Fernando Magdaleno; Daniel J Antoine; Rouchelle Dela Cruz; Neil Theise; Natalia Nieto
Journal:  Hepatology       Date:  2018-11-13       Impact factor: 17.425

Review 4.  Molecular pathways of nonalcoholic fatty liver disease development and progression.

Authors:  Fernando Bessone; María Valeria Razori; Marcelo G Roma
Journal:  Cell Mol Life Sci       Date:  2018-10-20       Impact factor: 9.261

5.  Silencing of α-complex protein-2 reverses alcohol- and cytokine-induced fibrogenesis in hepatic stellate cells.

Authors:  Hao Liu; Zhijin Chen; Wei Jin; Ashutosh Barve; Yu-Jui Yvonne Wan; Kun Cheng
Journal:  Liver Res       Date:  2017-06

6.  Systems level analysis and identification of pathways and networks associated with liver fibrosis.

Authors:  Mohamed Diwan M AbdulHameed; Gregory J Tawa; Kamal Kumar; Danielle L Ippolito; John A Lewis; Jonathan D Stallings; Anders Wallqvist
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

Review 7.  Biophysical, Biochemical, and Cell Based Approaches Used to Decipher the Role of Carbonic Anhydrases in Cancer and to Evaluate the Potency of Targeted Inhibitors.

Authors:  Mam Y Mboge; Anusha Kota; Robert McKenna; Susan C Frost
Journal:  Int J Med Chem       Date:  2018-07-16

8.  Ursolic acid reverses liver fibrosis by inhibiting interactive NOX4/ROS and RhoA/ROCK1 signalling pathways.

Authors:  Sizhe Wan; Fangyun Luo; Chenkai Huang; Cong Liu; Qingtian Luo; Xuan Zhu
Journal:  Aging (Albany NY)       Date:  2020-06-03       Impact factor: 5.682

9.  High mobility group box-1 promotes the proliferation and migration of hepatic stellate cells via TLR4-dependent signal pathways of PI3K/Akt and JNK.

Authors:  Fu-ping Wang; Lei Li; Jing Li; Ji-yao Wang; Ling-yan Wang; Wei Jiang
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

Review 10.  Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis.

Authors:  Isabel Fabregat; Daniel Caballero-Díaz
Journal:  Front Oncol       Date:  2018-09-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.